In addition, high expression of CAV1 predicted worse prognosis in OSCC, can inhibit ferroptosis and cisplatin sensitivity in cancer cells, promoting migration and invasion, and can affect the immune cell infiltration [75]. This evidence concerns the gene CAV1 and cancer.